Goldman Sachs’s Aura Biosciences AURA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.33M | Buy |
212,298
+90,654
| +75% | +$567K | ﹤0.01% | 3677 |
|
|
2025
Q1 | $713K | Sell |
121,644
-32,410
| -21% | -$190K | ﹤0.01% | 4036 |
|
|
2024
Q4 | $1.27M | Buy |
154,054
+40,082
| +35% | +$329K | ﹤0.01% | 3767 |
|
|
2024
Q3 | $1.02M | Sell |
113,972
-915,949
| -89% | -$8.16M | ﹤0.01% | 3745 |
|
|
2024
Q2 | $7.79M | Buy |
1,029,921
+33,278
| +3% | +$252K | ﹤0.01% | 2291 |
|
|
2024
Q1 | $7.82M | Sell |
996,643
-40,656
| -4% | -$319K | ﹤0.01% | 2247 |
|
|
2023
Q4 | $9.19M | Buy |
1,037,299
+44,097
| +4% | +$391K | ﹤0.01% | 2155 |
|
|
2023
Q3 | $8.91M | Sell |
993,202
-33,702
| -3% | -$302K | ﹤0.01% | 2068 |
|
|
2023
Q2 | $12.7M | Buy |
1,026,904
+738,406
| +256% | +$9.12M | ﹤0.01% | 1855 |
|
|
2023
Q1 | $2.68M | Buy |
288,498
+82,918
| +40% | +$769K | ﹤0.01% | 3004 |
|
|
2022
Q4 | $2.16M | Buy |
+205,580
| New | +$2.16M | ﹤0.01% | 3230 |
|